SCHEMBL7121453

SCHEMBL7121453

Cc1cc(NC(=O)CC(=O)O)cc(Cl)c1Oc1ccc(O)c(Cc2ccc(F)cc2)c1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
THRB P10828 15/20 0.67
THRA P10827 14/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4964919 0.93 THRB (0.72) THRBTHRA
SCHEMBL4965136 0.85 THRB (0.56) THRBTHRA
SCHEMBL23983024 0.82 THRA (0.60) THRBTHRA
SCHEMBL8800915 0.82 THRA (0.54) THRBTHRA
SCHEMBL18932861 0.82 THRA (0.54) THRBTHRA
SCHEMBL1641051 0.82 THRA (0.65) THRBTHRA
SCHEMBL4961521 0.82 THRA (0.65) THRBTHRA
SCHEMBL14489297 0.81 THRB (0.82) THRBTHRA
SCHEMBL8892318 0.81 THRA (0.54) THRBTHRA
SCHEMBL5401923 0.80 THRB (1.00) THRBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664291-B2 Aromatic amidealkyl acid or ester or amide or hydroxy derivatives are useful in the treatment of obesity, overweight condition, hyperlipidemia, glucoma, cardiac arrhythmias, thyroid disease, skin disoders and diabetes PFIZER, INC. 2003-12-16 US disclosed
US-20010051657-A1 Malonamic acids and derivatives thereof as thyroid receptor ligands PFIZER INC. 2001-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010051657-A1 Malonamic acids and derivatives thereof as thyroid receptor ligands THRA, MC1R, THRB THRB 3/4885THRA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.